Dose-Intense Temozolomide in Recurrent Glioblastoma
Clinical trial NCT00657267 · COMPLETED
Trial details
- NCT number
- NCT00657267
- Sponsor
- Patrick Y. Wen, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2011-11-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.